Clinical Trials Logo

Valley Fever clinical trials

View clinical trials related to Valley Fever.

Filter by:
  • None
  • Page 1

NCT ID: NCT04809649 Withdrawn - Coccidioidomycosis Clinical Trials

SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole

SITRIS
Start date: May 15, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine how safe, effective, and well tolerated a new investigational antifungal drug, SUBA-itraconazole, is for patients who have been previously treated with fluconazole and have had either an insufficient response to treatment with fluconazole or a negative reaction to fluconazole preventing their further treatment with it.

NCT ID: NCT03618992 Terminated - Coccidioidomycosis Clinical Trials

Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

This will be a multi-visit study that will take approximately 3 hours in total. Up to 200 subjects from the BUMC Valley Fever and BUMC Dermatology clinics will be enrolled in this study and assigned to one of three cohorts according to timeline of oral anti-fungal therapy. Subjects in Cohort 1 will be randomized to apply topical cholesterol-containing moisturizers to the skin, hair and lips on either the right or left side of the body daily. Measurements of skin barrier function, appearance of skin and hair, and hair samples will be obtained at baseline and at 4 week follow-up visits. Cohorts 2 and 3 will be observational groups at differing points in oral antifungal treatment regimen. Subjects will be randomized to have measurements of skin barrier function and hair and skin characteristics obtained from either the right or left side of the body at baseline and at monthly follow-up visits.